An Interdisciplinary Approach for the Management of the Elderly Multimorbid Patient with Breast Cancer Therapy Induced Cardiac Toxicity
Two papers, prepared by the UOI team, entitled “CARDIOCARE: An integrated platform for the management of elderly multimorbid patients with breast cancer therapy induced cardiac toxicity” and “Risk Stratification for Cardiotoxicity in Breast Cancer Patients: Predicting Early Decline of LVEF After Treatment” were accepted in EMBC 2023 that will be held in Syndey Australia, in July 2023. Really glad to participate!
Highlights
Dr. Kalliopi Keramida presented CARDIOCARE during her lecture on the "The effect of gender on the risk of cardiotoxicity" in the Round Table "Cardiological evaluation and monitoring of oncology patient" of the 7th Hellenic Congress of Oncology. The overall concept of...
Dr. Kalliopi Keramida presented CARDIOCARE during her lecture on "Monitoring cardiovascular complications during cancer therapy" in the Cardiotoxicity Session in the Cardiovascular Imaging Congress that held from 12th to 13th of April 2024 in Athens. The overall...
CARDIOCARE was presented in an event organized by Dr. Athos Antoniades, CEO and Head of Research at STREMBLE Ventures LTD and member of the CARDIOCARE team. The event had a title "Scientific leadership in international projects and opportunities to collaborate with a...